
Brand Insights - Thought Leadership | Paid Program | Veradigm


Contrasting the view of heart failure patients as seen from the perspectives of two large but distinct sources of real-world data: the Veradigm Cardiology Registry and Practice Fusion
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
2
OTR Therapeutics Announces Collaboration with Zealand Pharma to Develop Metabolic Disease Treatments
3
The Cost of Fixing Pharma
4
EU Opportunities: How EMA Support Programs Can Slash Drug Market Entry Costs by 90%
5
